Open AccessRisk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study
Author(s) -
ChiChih Wang,
MingChang Tsai,
WenWei Sung,
TzuWei Yang,
HsuanYi Chen,
YaoTung Wang,
ChangCheng Su,
MingHseng Tseng,
ChungYen Lin
Publication year - 2019
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v11.i3.238
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , cholecystectomy , odds ratio , incidence (geometry) , population , gastroenterology , general surgery , pancreatitis , environmental health , physics , optics
Cholangiocarcinoma is a highly lethal disease that had been underestimated in the past two decades. Many risk factors are well documented for in cholangiocarcinoma, but the impacts of advanced biliary interventions, like endoscopic sphincterotomy (ES), endoscopic papillary balloon dilatation (EPBD), and cholecystectomy, are inconsistent in the previous literature.